Aditxt is trading 5.71% higher at $0.01, with no clear company-specific catalyst identified for September 14, 2026.
- Recent coverage mainly references earlier financing disclosures and the Ignite Proteomics transaction, rather than a new event tied to today’s move.
- The broader market is weaker, so overall market direction does not appear to explain the advance.